Ditchcarbon
  • Contact
  1. Organizations
  2. Catalent
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 13 days ago

Catalent

Company website

Catalent, Inc., a leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, and consumer health products, is headquartered in the United States. Founded in 2007, Catalent has rapidly expanded its operations across North America, Europe, and Asia, establishing a strong presence in the pharmaceutical and biotechnology industries. The company is renowned for its innovative services, including drug formulation, clinical supply, and commercial manufacturing, which are designed to enhance product performance and patient experience. Catalent's commitment to quality and efficiency has positioned it as a trusted partner for many of the world's top pharmaceutical companies. With a focus on continuous improvement and cutting-edge technology, Catalent remains at the forefront of the industry, achieving significant milestones in drug delivery and development.

DitchCarbon Score

How does Catalent's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

41

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Catalent's score of 41 is higher than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.

61%

Let us know if this data was useful to you

Catalent's reported carbon emissions

In 2023, Catalent, headquartered in the US, reported total carbon emissions of approximately 134,100,000 kg CO2e for Scope 1 and 2 combined, with Scope 1 emissions at about 12,400,000 kg CO2e and Scope 2 emissions at approximately 39,600,000 kg CO2e (market-based). The company has set ambitious targets to reduce its carbon footprint, committing to a 42% reduction in absolute Scope 1 and 2 greenhouse gas emissions by fiscal year 2030, using fiscal year 2022 as the baseline. Additionally, Catalent aims to decrease its Scope 3 emissions—specifically from fuel- and energy-related activities and employee commuting—by 25% within the same timeframe. Furthermore, the company plans for 70% of its suppliers, based on emissions, to establish science-based targets by fiscal year 2028. These commitments align with industry standards and reflect Catalent's dedication to addressing climate change and reducing its environmental impact.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20192020202120222023
Scope 1
61,000,000
-
-
00,000,000
00,000,000
Scope 2
144,000,000
000,000,000
000,000,000
00,000,000
00,000,000
Scope 3
-
-
-
000,000,000
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Catalent's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Catalent is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Catalent is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Porton Pharma Solutions

CN
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Asymchem Laboratories

CN
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Sartorius

DE
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 3 days ago

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated about 9 hours ago

MERCK Kommanditgesellschaft auf Aktien

DE
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Shanghai SynTheAll Pharmaceutical Co., Ltd.

CN
•
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251029.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy